Hims & Hers Health, Inc. reported strong financial results for the third quarter of 2024. The company achieved a revenue of $401.6 million, marking a 77% year-over-year increase, surpassing the estimated $382.2 million. Net income reached $75.6 million, supported by a $60.8 million tax benefit. The company also reported an adjusted EBITDA of $51.1 million, significantly up from $12.3 million in the previous year. Earnings per share (EPS) were $0.32, well above the estimated $0.04, with adjusted EPS at approximately $0.07. The number of subscribers grew by 44% to 2 million. Hims & Hers raised its full-year guidance, expecting revenue between $1.46 billion and $1.465 billion, compared to the previous estimate of $1.4 billion. For the fourth quarter, the company projects revenue between $465 million and $470 million. The CEO attributed the strong performance to rapid consumer adoption and robust margins. Post market, the stock was up 4%.